New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury-Reference-Cited by-同舟云学术

New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury

Published:2017-10-18 Issue:15 Volume:18 Page:
ISSN:1389-4501
Container-title:Current Drug Targets
language:en
Short-container-title:CDT

Author:

Chin Kai Yee¹,Qin Chengxue²,May Lauren³,Ritchie Rebecca H.²,Woodman Owen L.⁴

Affiliation:

1. School of Medical Sciences, RMIT University, Bundoora, Australia

2. Baker IDI Heart & Diabetes Institute, Melbourne, Australia

3. Department of Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, and Department of Pharmacology, Monash University, Parkville, Australia

4. School of Medical Sciences, RMIT University, PO Box 83 Bundoora, Vic, 3083, Australia

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ZBP1-mediated PANoptosis: A possible novel mechanism underlying the therapeutic effects of penehyclidine hydrochloride on myocardial ischemia–reperfusion injury;International Immunopharmacology;2024-08

2. Microvascular dysfunction in heart transplantation is associated with altered cardiomyocyte mitochondrial structure and unimpaired excitation-contraction coupling;PLOS ONE;2024-05-31

3. The role of β‐adrenergic receptors in the regulation of cardiac tolerance to ischemia/reperfusion. Why do β‐adrenergic receptor agonists and antagonists protect the heart?;Fundamental & Clinical Pharmacology;2024-02-29

4. Platelet Membrane‐Fused Circulating Extracellular Vesicles Protect the Heart from Ischemia/Reperfusion Injury;Advanced Healthcare Materials;2023-05-10

5. Pharmacological Modulation by Low Molecular Weight Heparin of Purinergic Signaling in Cardiac Cells Prevents Arrhythmia and Lethality Induced by Myocardial Infarction;Journal of Cardiovascular Development and Disease;2023-02-27